Cargando…
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital
SIMPLE SUMMARY: Cancer patients may have increased risk from COVID-19 due to impaired fitness and immunosuppression secondary to underlying cancer and the effects of anti-cancer treatments. We previously demonstrated that solid cancer and anti-cancer treatments may be associated with increased death...
Autores principales: | Wong, Yien Ning Sophia, Sng, Christopher C. T., Ottaviani, Diego, Patel, Grisma, Chowdhury, Amani, Earnshaw, Irina, Sinclair, Alasdair, Merry, Eve, Wu, Anjui, Galazi, Myria, Benafif, Sarah, Soosaipillai, Gehan, Chopra, Neha, Roylance, Rebecca, Shaw, Heather, Lee, Alvin J. X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657102/ https://www.ncbi.nlm.nih.gov/pubmed/34885194 http://dx.doi.org/10.3390/cancers13236085 |
Ejemplares similares
-
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience
por: Sng, Christopher C. T., et al.
Publicado: (2020) -
1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital
por: Sinclair, A., et al.
Publicado: (2021) -
1704P COVID-19 mortality in patients receiving anti-cancer therapy in a UK national cancer centre
por: Wu, A., et al.
Publicado: (2020) -
1734P Do cancer patients really do worse? A study in a UK tertiary hospital within a COVID-19 epicentre
por: Sng, C.C.T., et al.
Publicado: (2020) -
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
por: Soosaipillai, Gehan, et al.
Publicado: (2021)